Literature DB >> 8798354

Gastric smooth muscle tumors: diagnostic dilemmas and factors affecting outcome.

L Sanders1, M Silverman, R Rossi, J Braasch, L Munson.   

Abstract

We reviewed the 46 gastric stromal tumors that were treated at our institution between 1958 and 1992. The most common presenting symptoms were gastrointestinal bleeding, pain, and fatigue or malaise. The tumors ranged from 4 to 150 mm, with surgery most often being a wedge excision or partial gastrectomy. Abdominal computed tomography was the most specific diagnostic test obtained preoperatively. Factors associated with decreased survival included size >/= 8 cm (p = 0.02), more than 0-3 mitoses per 10 HPF (p < 0. 001), positive margins or unresectability (p = 0.008), and tumor pathologic grade II or more (p = 0.004). These tumors have an unpredictable behavior. Surgical resection with negative margins remains the best therapy, but resection for palliation is sometimes indicated as it can be associated with prolonged survival.

Entities:  

Mesh:

Year:  1996        PMID: 8798354     DOI: 10.1007/s002689900150

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  [Cystic space-occupying lesion of the bursa omentalis].

Authors:  S Metz; J Stollfuss; K Wörtler; E J Rummeny
Journal:  Radiologe       Date:  2002-04       Impact factor: 0.635

2.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

4.  Gastric stromal tumours: a practical approach.

Authors:  N Mihssin; K Moorthy; A Sengupta; P W Houghton
Journal:  Ann R Coll Surg Engl       Date:  2000-11       Impact factor: 1.891

5.  Laparoscopic vs open resection of gastric stromal tumors.

Authors:  B D Matthews; R M Walsh; K W Kercher; R F Sing; B L Pratt; G A Answini; B T Heniford
Journal:  Surg Endosc       Date:  2002-02-08       Impact factor: 4.584

6.  Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.

Authors:  Halil Ozgüç; Tuncay Yilmazlar; Omer Yerci; Rusen Soylu; Volkan Tümay; Gülaydan Filiz; Abdullah Zorluoglu
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

7.  A new "no-touch" technique for the laparoscopic treatment of gastric stromal tumors.

Authors:  E Yahchouchy-Chouillard; J-C Etienne; P-L Fagniez; R Adam; A Fingerhut
Journal:  Surg Endosc       Date:  2002-02-27       Impact factor: 4.584

8.  Computed tomography in gastrointestinal stromal tumors.

Authors:  Nadir Ghanem; Carsten Altehoefer; Alex Furtwängler; Jan Winterer; Oliver Schäfer; Oliver Springer; Elmar Kotter; Mathias Langer
Journal:  Eur Radiol       Date:  2003-02-19       Impact factor: 5.315

9.  Laparoscopic resection of gastric GIST and benign gastric tumours: evolution of a new technique.

Authors:  A A Warsi; P M Peyser
Journal:  Surg Endosc       Date:  2009-06-17       Impact factor: 4.584

10.  Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

Authors:  Burton L Eisenberg; Jonathan Harris; Charles D Blanke; George D Demetri; Michael C Heinrich; James C Watson; John P Hoffman; Scott Okuno; John M Kane; Margaret von Mehren
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.